Scientific Articles

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S1, Lonardi S1, Elez E1, Kim TW1, Schellens JHM1, Guo C1, Krishnan A1, Dekervel J1, Morris V1, Calvo Ferrandiz A1, Tarpgaard LS1, Braun M1, Gollerkeri A1, Keir C1, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J.

 

The New England Journal of Medicine, 2019 Oct. 24
Privacy Overview
AIOM

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.